[Evaluation of clinical usefulness of direct drug injections for increasing local circulation, into cavernous bodies of the penis for treatment of erection impotence in patients with diabetes mellitus].
The study aimed at comparing an effectiveness of drugs increasing local blood flow injected into cavernous bodies of penis in the treatment of erective impotence in diabetic patients. Fifteen diabetic patients aged between 33 and 60 years with impotence lasting for 4 years have been selected. Patients have been treated with papaverine HCl in the dose of 20-40 mg, papaverine HCl in the same dose combined with phentolamine 5 mg, and prostaglandin E1 in the dose of 20 micrograms. Each patient has been all tested drugs. The most favourable results, i.e. most effective and without adverse reactions (priapism), have been produced by prostaglandin E1 which seems a drug of choice in the treatment of erective impotence in patients with long-lasting diabetes mellitus.
Dembe
K
K
Kliniki Gastroenterologii i Chorób Przemiany Materii AM, Warszawie.
Jasik
M
M
Piechna
K
K
D000328:Adult; D048909:Diabetes Complications; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage*; D010410:Penile Erection / Q000187:drug effects*; D010413:Penis / Q000098:blood supply*; D012039:Regional Blood Flow / Q000187:drug effects
D010208:Papaverine
Ocena przydatności klinicznej wstrzyknieć do ciał jamistych leków zwiekszajacych miejscowy przepływ naczyniowy w leczeniu impotencji erekcyjnej u chorych na cukrzyce.